✦ LIBER ✦
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts
✍ Scribed by Daniel L. Gustafson; Barbara Frederick; Andrea L. Merz; David Raben
- Book ID
- 105992616
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 481 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.